A potent α/β-peptide analogue of GLP-1 with prolonged action in vivo.
about
Transmembrane signal transduction by peptide hormones via family B G protein-coupled receptorsDiscovery and characterization of smORF-encoded bioactive polypeptidesProtein-Protein Interactions Mediated by Helical Tertiary Structure Motifs.Folding and function in α/β-peptides: targets and therapeutic applications.Targeting diverse protein-protein interaction interfaces with α/β-peptides derived from the Z-domain scaffold.Improving the Binding Affinity of in-Vitro-Evolved Cyclic Peptides by Inserting Atoms into the Macrocycle Backbone.Selective VIP Receptor Agonists Facilitate Immune Transformation for Dopaminergic Neuroprotection in MPTP-Intoxicated Mice.An optimal hydrogen-bond surrogate for α-helices.Engineering a long-acting, potent GLP-1 analog for microstructure-based transdermal delivery.Design of Potent and Proteolytically Stable Oxyntomodulin Analogs.An overview of peptide and peptoid foldamers in medicinal chemistry.Modified human glucagon-like peptide-1 (GLP-1) produced in E. coli has a long-acting therapeutic effect in type 2 diabetic mice.Systematic Targeting of Protein-Protein InteractionsCharacterization of signal bias at the GLP-1 receptor induced by backbone modification of GLP-1.Targeting recognition surfaces on natural proteins with peptidic foldamersIterative Nonproteinogenic Residue Incorporation Yields α/β-Peptides with a Helix-Loop-Helix Tertiary Structure and High Affinity for VEGF.Solution Observation of Dimerization and Helix Handedness Induction in a Human Carbonic Anhydrase-Helical Aromatic Amide Foldamer Complex.α/β-Peptide Foldamers Targeting Intracellular Protein-Protein Interactions with Activity in Living Cells.Backbone Modification of a Parathyroid Hormone Receptor-1 Antagonist/Inverse Agonistβ-Arrestin-Biased Agonists of the GLP-1 Receptor from β-Amino Acid Residue Incorporation into GLP-1 Analogues.Development of Potent, Protease-Resistant Agonists of the Parathyroid Hormone Receptor with Broad β Residue Distribution.Rotamer Libraries for the High-Resolution Design of β-Amino Acid Foldamers.Quaternary β2,2 -Amino Acids: Catalytic Asymmetric Synthesis and Incorporation into Peptides by Fmoc-Based Solid-Phase Peptide Synthesis.N-Gemini peptides: cytosolic protease resistance via N-terminal dimerization of unstructured peptides.Beta amino acid-modified and fluorescently labelled kisspeptin analogues with potent KISS1R activity.
P2860
Q28082755-BC12F982-87F2-4F12-B179-39B82A624860Q28829292-77A7D6A9-920C-46BB-9545-D08EC984708BQ30378305-A46349C4-6ACA-47C6-952B-CC6E64E51567Q34483276-0C974CA5-7193-4D3B-AB48-91A00BD12E09Q35484964-FF137C58-5FD3-44F0-86CC-54DB953AB6F1Q36197974-4145ACB7-461B-4DB4-9C82-2DEF6791E942Q36373813-9E8143AF-C60B-4512-9F17-418F08C037E5Q36813449-1EAA01C5-2F5C-492D-8C41-5BE9CB0887F6Q36821353-4279D4AB-56C1-44C8-AD03-29FB1254F875Q36884113-2DFCEE99-4BEF-448E-A01F-F44054B81CA9Q38569751-79A54C9F-AA3E-4E75-8551-5F4F87D728D9Q38696282-740F866F-0D54-41AF-9221-9FD9A7063583Q38856802-57E40CD0-60C4-4235-8F2A-63F2589A562AQ38864019-25E6204E-BCC5-4AE4-ACFD-CCDA0A034EACQ38889986-76207847-F512-448E-8FE7-7D46938F6299Q39145905-179C316A-E47A-46AF-B82D-0B662804AB78Q40065435-5CAFE121-B1A8-412A-87DA-3F9DA056398BQ40596592-28611A20-D3AD-4B61-B8CE-328D791560B1Q42369377-6CFC5D83-2BB2-475D-BD9F-D147E8905A21Q43294448-73C9A4A9-4306-4EB5-AD1D-1B0419B0DBFEQ47416630-CA905128-1AE1-4210-B310-A34EA507E777Q47649631-DFCC7D12-A871-4F9E-B395-12F9349E02D8Q48248391-61B02BBA-6CFF-458A-ABCC-915F871D0EABQ48572712-785C6100-011E-4675-8D9A-F2D5709E11FBQ48686268-10384A09-0D98-4FD4-B9BD-7F3712CD4E3A
P2860
A potent α/β-peptide analogue of GLP-1 with prolonged action in vivo.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A potent α/β-peptide analogue of GLP-1 with prolonged action in vivo.
@ast
A potent α/β-peptide analogue of GLP-1 with prolonged action in vivo.
@en
A potent α/β-peptide analogue of GLP-1 with prolonged action in vivo.
@nl
type
label
A potent α/β-peptide analogue of GLP-1 with prolonged action in vivo.
@ast
A potent α/β-peptide analogue of GLP-1 with prolonged action in vivo.
@en
A potent α/β-peptide analogue of GLP-1 with prolonged action in vivo.
@nl
prefLabel
A potent α/β-peptide analogue of GLP-1 with prolonged action in vivo.
@ast
A potent α/β-peptide analogue of GLP-1 with prolonged action in vivo.
@en
A potent α/β-peptide analogue of GLP-1 with prolonged action in vivo.
@nl
P2093
P2860
P356
P1476
A potent α/β-peptide analogue of GLP-1 with prolonged action in vivo.
@en
P2093
Alan D Attie
Alan Saghatelian
Alessandro Bisello
Amanda McFedries
Edwin A Homan
Lisa M Johnson
Mark P Keller
Marlies V Hager
Mary E Rabaglia
Samuel H Gellman
P2860
P304
12848-12851
P356
10.1021/JA507168T
P407
P577
2014-09-05T00:00:00Z